IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 304 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | 0.0% | 52 | 0.0% | 0.00% | – |
| Q2 2023 | $2 | 0.0% | 52 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | +100.0% | 52 | +108.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 25 | -97.2% | 0.00% | – |
| Q1 2022 | $33,000 | +22.2% | 900 | 0.0% | 0.00% | – |
| Q4 2021 | $27,000 | -10.0% | 900 | 0.0% | 0.00% | – |
| Q3 2021 | $30,000 | -16.7% | 900 | 0.0% | 0.00% | – |
| Q2 2021 | $36,000 | -21.7% | 900 | -12.5% | 0.00% | – |
| Q1 2021 | $46,000 | -9.8% | 1,029 | +14.3% | 0.00% | – |
| Q4 2020 | $51,000 | +18.6% | 900 | 0.0% | 0.00% | – |
| Q3 2020 | $43,000 | -18.9% | 900 | 0.0% | 0.00% | – |
| Q2 2020 | $53,000 | +23.3% | 900 | 0.0% | 0.00% | – |
| Q1 2020 | $43,000 | -20.4% | 900 | 0.0% | 0.00% | – |
| Q4 2019 | $54,000 | -5.3% | 900 | -5.3% | 0.00% | – |
| Q3 2019 | $57,000 | -6.6% | 950 | 0.0% | 0.00% | – |
| Q2 2019 | $61,000 | -16.4% | 950 | +5.6% | 0.00% | – |
| Q1 2019 | $73,000 | +49.0% | 900 | 0.0% | 0.00% | – |
| Q4 2018 | $49,000 | +6.5% | 900 | 0.0% | 0.00% | – |
| Q3 2018 | $46,000 | +21.1% | 900 | 0.0% | 0.00% | – |
| Q2 2018 | $38,000 | -5.0% | 900 | 0.0% | 0.00% | – |
| Q1 2018 | $40,000 | -35.5% | 900 | -27.5% | 0.00% | – |
| Q4 2017 | $62,000 | -1.6% | 1,242 | 0.0% | 0.00% | – |
| Q3 2017 | $63,000 | 0.0% | 1,242 | 0.0% | 0.00% | – |
| Q2 2017 | $63,000 | -78.6% | 1,242 | -83.0% | 0.00% | -100.0% |
| Q1 2017 | $294,000 | +583.7% | 7,318 | +713.1% | 0.00% | – |
| Q4 2016 | $43,000 | +30.3% | 900 | 0.0% | 0.00% | – |
| Q3 2016 | $33,000 | -23.3% | 900 | -51.3% | 0.00% | – |
| Q2 2016 | $43,000 | -34.8% | 1,847 | +12.9% | 0.00% | – |
| Q1 2016 | $66,000 | 0.0% | 1,636 | +54.8% | 0.00% | – |
| Q4 2015 | $66,000 | – | 1,057 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |